Relmada Therapeutics, Inc. (RLMD): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2020-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$209.86M

Year ended 2020-12-31

2013-12-31 Free Cash Flow (USD) 2020-12-31

Period ended	Free Cash Flow	Change YoY	Source filing
2020-12-31	-$209.86M	n/m	2022-03-25, From 2020-01-01
2019-12-31	-$96.94M	n/a	2021-03-24, From 2019-01-01
No annual figure between 2018-06-30 and 2019-12-31.
2018-06-30	-$6.01M	n/m	2019-09-24, From 2017-07-01
2017-06-30	-$6.52M	n/m	2018-09-28, From 2016-07-01
2016-06-30	-$13.71M	n/m	2017-09-28, From 2015-07-01
2015-06-30	-$16.25M	n/a	2016-09-09, From 2014-07-01
No annual figure between 2013-12-31 and 2015-06-30.
2013-12-31	-$2.25M	n/a	2015-09-11, From 2013-01-01